Insulin-like growth factor 1 ( IGF 1 ) , IGF binding protein 3 ( IGFBP 3 ) , and breast cancer risk : pooled individual data analysis of 17 prospective studies

Correspondence to: Prof Tim Key, Endogenous Hormones and Breast Cancer Collaborative Group, Cancer Epidemiology Unit, Nuffi eld Department of Clinical Medicine, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK tim.key@ceu.ox.ac.uk Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

[1]  C. McCarty,et al.  Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Protein (IGFBP)-3 Levels and Postmenopausal Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort , 2010, Hormones & cancer.

[2]  G. Brabant,et al.  Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. , 2009, European journal of endocrinology.

[3]  I. Gram,et al.  The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  Thomas E Rohan,et al.  Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.

[5]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[6]  J. Holly,et al.  IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology , 2008, Journal of Mammary Gland Biology and Neoplasia.

[7]  L. Vatten,et al.  Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway , 2008, Cancer Epidemiology Biomarkers & Prevention.

[8]  S. Hankinson,et al.  Body shape throughout life and correlations with IGFs and GH. , 2007, Endocrine-related cancer.

[9]  G. Brabant,et al.  Normal levels of serum IGF-I: determinants and validity of current reference ranges , 2007, Pituitary.

[10]  D. English,et al.  Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[12]  Adrian V. Lee,et al.  Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. , 2006, The Journal of endocrinology.

[13]  D. Spiegelman,et al.  Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.

[14]  D. Hunter,et al.  Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. , 2006, Endocrine-related cancer.

[15]  F Berrino,et al.  IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). , 2006, Endocrine-related cancer.

[16]  A. Howell,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. , 2006, Endocrine-related cancer.

[17]  A. Trichopoulou,et al.  Are mammotropic hormones mainly permissive for the development of breast cancer? , 2006, International journal of cancer.

[18]  D. Spiegelman,et al.  Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  K. Helzlsouer,et al.  Premenopausal levels of circulating insulin‐like growth factor I and the risk of postmenopausal breast cancer , 2006, International journal of cancer.

[20]  F. Berrino,et al.  IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[21]  J. Chang-Claude,et al.  Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. , 2005, Endocrine-related cancer.

[22]  J. Potter,et al.  Variation in Plasma Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3: Personal and Lifestyle Factors (United States) , 2005, Cancer Causes & Control.

[23]  A. Roddam,et al.  A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk , 2005, British Journal of Cancer.

[24]  S. Hankinson,et al.  Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[25]  L. Wilhelmsen,et al.  Insulin-Like Growth Factor I Levels in Healthy Adults , 2005, Hormone Research in Paediatrics.

[26]  S. Hankinson,et al.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. , 2004, Journal of the National Cancer Institute.

[27]  A. Tjønneland,et al.  Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  B. Bonanni,et al.  Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer , 2004, Breast Cancer Research and Treatment.

[29]  M. Bartucci,et al.  Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. , 2004, Journal of experimental & clinical cancer research : CR.

[30]  B. Henderson,et al.  Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  E. Riboli,et al.  Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer , 2003, International journal of cancer.

[32]  N. Probst-Hensch,et al.  Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  G. Brabant,et al.  Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study , 2003, Hormone Research in Paediatrics.

[34]  R. Krajcik,et al.  Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. , 2002, Clinical chemistry.

[35]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[36]  F. Berrino,et al.  Fasting glucose is a risk factor for breast cancer: a prospective study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  E. Riboli,et al.  Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) , 2002, Cancer Causes & Control.

[38]  E. Riboli,et al.  Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden , 2002, Cancer Causes & Control.

[39]  E. Riboli,et al.  A cross-sectional study of IGF-I determinants in women , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  S. Narod,et al.  Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[42]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[43]  S. Cummings,et al.  Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer , 1999, Annals of Internal Medicine.

[44]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[45]  E. Barrett-Connor,et al.  Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. , 1997, American journal of epidemiology.

[46]  R. Margolese,et al.  Presence of somatomedin receptors on primary human breast and colon carcinomas. , 1987, Cancer letters.

[47]  W. Willett,et al.  Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  R. Krajcik,et al.  Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.

[50]  D. Clemmons,et al.  Factors controlling blood concentration of somatomedin C. , 1984, Clinics in endocrinology and metabolism.